Clinical Trial Results:
Impact of a treatment with zoledronic acid on bone mineral density in patients with metastatic castration-resistant prostate cancer, chemo-naïve and receiving abiraterone acetate
Summary
|
|
EudraCT number |
2013-001146-34 |
Trial protocol |
FR |
Global completion date |
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
26 Oct 2022
|
First version publication date |
26 Oct 2022
|
Other versions |
|
Summary report(s) |
RRF_AZALEE |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.